Search results
Results from the WOW.Com Content Network
The company is a spin-off from the Max Planck Institute for Biophysical Chemistry. [6] In 2002, Alnylam was founded by scientists Phillip Sharp, Paul Schimmel, David Bartel, Thomas Tuschl, and Phillip Zamore, and by investors Christoph Westphal and John Kennedy Clarke; John Maraganore was the founding CEO.
In this article we will take a look at whether hedge funds think Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a good investment right now. We check hedge fund and billionaire investor sentiment ...
Alnylam (ALNY) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Alnylam (ALNY) saw a big move last session, as its shares jumped nearly 11% on the day, amid huge volumes.
Yvonne Greenstreet is the daughter of a Ghanaian mother, Miranda Greenstreet, and a white Englishman. The pair met in the 1950s as students at the London School of Economics.
In April 2008, Regulus and GlaxoSmithKline (GSK) entered into a microRNA-focused strategic alliance for the discovery, development and commercialization of novel microRNA-targeted therapeutics to treat inflammatory diseases such as rheumatoid arthritis.
Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alexei Anatolyevich Navalny [c] [d] (Russian: Алексей Анатольевич Навальный, IPA: [ɐlʲɪkˈsʲej ɐnɐˈtolʲjɪvʲɪtɕ nɐˈvalʲnɨj]; 4 June 1976 – 16 February 2024) was a Russian opposition leader, [2] [3] anti-corruption activist and political prisoner. [4]